Table 3.
Presentations/conditions | Factors | Percentagea | χ2 p-value | Odds ratio | 95% CI | p-value |
---|---|---|---|---|---|---|
Clinical presentations | ||||||
Pneumonia | Delta | 69.6% | <0.001* | 8.127 | 3.080–21.443 | <0.001* |
Omicron | 22.0% | |||||
Sore throat | Delta | 26.1% | 0.004* | 0.276 | 0.112–0.681 | 0.005* |
Omicron | 56.1% | |||||
Congestion or runny nose | Delta | 28.3% | 0.016* | 0.340 | 0.140–0.827 | 0.017* |
Omicron | 53.7% | |||||
Headache | Delta | 8.7% | 0.025* | 0.260 | 0.075–0.894 | 0.033* |
Omicron | 26.8% | |||||
Shortness of breath | Asthma | 50.0% | 0.008* | 10.857 | 1.320–89.312 | 0.027* |
No Asthma | 8.4% | |||||
Hematologic disease | 66.7% | 0.001* | 22.000 | 1.766–273.997 | 0.016* | |
No hematologic disease | 8.3% | |||||
Underlying conditions | ||||||
Hypertension | Delta | 26.1% | 0.049* | 0.409 | 0.166–1.005 | 0.051 |
Omicron | 46.3% | |||||
Age ≥ 60 | 64.5% | <0.001* | 7.438 | 2.770–19.975 | <0.001* | |
Age 18–59 | 19.6% | |||||
Dyslipidemia | Delta | 21.7% | 0.015* | 0.322 | 0.127–0.816 | 0.017* |
Omicron | 46.3% | |||||
Age ≥ 60 | 61.3% | <0.001* | 7.283 | 2.693–19.699 | <0.001* | |
Age 18–59 | 17.9% | |||||
Obesity | Age ≥ 60 | 9.7% | 0.028* | 0.246 | 0.066–0.920 | 0.037* |
Age 18–59 | 30.4% | |||||
Diabetes | Age ≥ 60 | 32.3% | 0.013* | 3.968 | 1.278–12.324 | 0.017* |
Age 18–59 | 10.7% | |||||
Adjusted odds ratio | ||||||
Dyslipidemia | Delta | 0.361 | 0.130–1.005 | 0.051 | ||
Omicron | ||||||
Age ≥ 60 | 6.819 | 2.456–18.931 | <0.001* | |||
Age 18–59 |
a, Percentage of participants presented with the clinical presentations or conditions in each factor category; *, statistically significant at p ≤ 0.05